A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features (CTMS# 23-0012)
Lay Description
Category
- Child Health
- IRB Number
- 20230110HU
- NCT Number
- NCT # not yet entered
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Virginia Diaz
210-562-9149
diazvr@uthscsa.edu
Jaclyn Hung
210-450-5358
hungj@uthscsa.edu
Principal Investigator
Shafqat Shah